CXCR5 and benign prostatic hyperplasia: However, we note that expression of the CXCL13 receptor CXCR5, by quantitative reverse transcription PCR (qRT-PCR), was substantially lower compared with IGF1R in BPH-1 spheroids and BPH organoids (Supplemental Figure 5).